文献速递其他结缔组织病

髓系树突状细胞亚群在包涵体肌炎肌肉中的特征及其与IFN-γ通路和效应T细胞标志物的相关性

Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers.
PubMed 文献 · Ann Rheum Dis · 2026-05-06

该研究利用单核RNA测序、批量RNA测序及免疫组化/免疫荧光,分析包涵体肌炎(IBM)患者骨骼肌中髓系树突状细胞(mDC)亚群。发现cDC1、cDC2和mregDC三种mDC亚群在IBM肌肉中相对增加,尤其cDC1与KLRG1、TBX21等IBM特异性炎症标志物强相关,并表达KLRG1配体CDH1/CDH2及IL12B,可能为效应T细胞提供信号。

要点

  • IBM患者骨骼肌中cDC1、cDC2和mregDC三种mDC亚群相对增加,以cDC1最为突出。
  • cDC1与IBM特异性炎症标志物KLRG1和TBX21强相关。
  • cDC1特异性表达KLRG1配体CDH1和CDH2,并与mregDC共同表达IL12B。

核心结论

  • IBM患者骨骼肌以mDC亚群为特征,这些亚群与细胞毒性T细胞标志物和1型炎症相关。

研究设计与样本

  • 研究分析3个单核RNA测序数据集以识别、定量和表征cDC1、cDC2和mregDC三种mDC亚群。
  • 研究分析2个批量RNA测序数据集以关联mDC亚群标志物与IBM疾病活动标志物。
  • 研究使用免疫组化和免疫荧光确认mDC的存在。

主要发现

  • 所有3种mDC亚群,尤其是cDC1细胞,在IBM患者肌肉中相对增加,并与IBM特异性炎症标志物KLRG1和TBX21强相关。
  • cDC1细胞特异性表达KLRG1配体CDH1和CDH2,并与mregDC细胞共同表达IL12B,可能为IBM中效应T细胞提供邻分泌和旁分泌信号。

临床怎么用

  • IBM肌肉中mDC亚群(尤其cDC1)及其与KLRG1/TBX21的相关性,提示其可能参与驱动1型炎症和细胞毒性T细胞效应,但尚需进一步验证临床转化价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inclusion body myositis (IBM) is an idiopathic inflammatory myopathy characterised by type 1 inflammation, driven by muscle-infiltrating KLRG1+ and TBX21+ cytotoxic T cells. However, the cellular sources of the stimuli that trigger this effector response in the muscle of patients with IBM remain unclear. Given their role as antigen-presenting cells, we hypothesised that these may be myeloid dendritic cells (mDCs), which have previously been reported in skeletal muscle of patients with IBM. We used immunohistochemistry, immunofluorescence, single-nucleus RNA-sequencing (snRNA-seq) and bulk RNA-sequencing (RNA-seq) data from skeletal muscle of patients with IBM, other myositis, and controls to identify mDCs and characterise their contribution to IBM inflammation. METHODS: We first analysed snRNA-seq data from 3 datasets to identify, quantify, and characterise 3 mDC subsets: type 1 conventional dendritic (cDC1) cells, type 2 conventional dendritic (cDC2) cells, and mature immunoregulatory dendritic (mregDC) cells. We then analysed RNA-seq data from 2 datasets to correlate specific markers of these subsets with markers of IBM disease activity. We used immunohistochemistry and immunofluorescence to confirm mDC presence. RESULTS: All 3 mDC subsets, and especially cDC1 cells, are relatively increased in the muscle of patients with IBM and correlate strongly with IBM-specific inflammatory markers, including KLRG1 and TBX21. In particular, cDC1 cells specifically express the KLRG1 ligands, CDH1 and CDH2, and, along with mregDC cells, IL12B, representing possible juxtacrine and paracrine signals for effector T cells in IBM. CONCLUSIONS: Skeletal muscle of patients with IBM is specifically characterised by mDC subsets that correlate with markers of cytotoxic T cells and type 1 inflammation.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kirou RA, Pinal-Fernandez I, Casal-Dominguez M, et al. Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers. Ann Rheum Dis. 2026. PMID: 42091395. doi:10.1016/j.ard.2026.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。